BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer.
Shunan WangXinyu LiuMeng YangDongqi YuanKui YeXin QuXinchao WangPublished in: Disease markers (2022)
We speculate that BUB1, BUB1B, and BUB3 may be therapeutic targets for BrCa patients and also provide new therapeutic strategies for BrCa treatment.